1. Home
  2. ACHV vs WHG Comparison

ACHV vs WHG Comparison

Compare ACHV & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • WHG
  • Stock Information
  • Founded
  • ACHV N/A
  • WHG 1983
  • Country
  • ACHV Canada
  • WHG United States
  • Employees
  • ACHV N/A
  • WHG N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • WHG Investment Managers
  • Sector
  • ACHV Health Care
  • WHG Finance
  • Exchange
  • ACHV Nasdaq
  • WHG Nasdaq
  • Market Cap
  • ACHV 149.6M
  • WHG 148.5M
  • IPO Year
  • ACHV N/A
  • WHG 2002
  • Fundamental
  • Price
  • ACHV $4.29
  • WHG $16.37
  • Analyst Decision
  • ACHV Strong Buy
  • WHG
  • Analyst Count
  • ACHV 5
  • WHG 0
  • Target Price
  • ACHV $14.80
  • WHG N/A
  • AVG Volume (30 Days)
  • ACHV 120.7K
  • WHG 22.7K
  • Earning Date
  • ACHV 11-07-2024
  • WHG 10-30-2024
  • Dividend Yield
  • ACHV N/A
  • WHG 3.69%
  • EPS Growth
  • ACHV N/A
  • WHG N/A
  • EPS
  • ACHV N/A
  • WHG 0.32
  • Revenue
  • ACHV N/A
  • WHG $92,368,000.00
  • Revenue This Year
  • ACHV N/A
  • WHG N/A
  • Revenue Next Year
  • ACHV N/A
  • WHG N/A
  • P/E Ratio
  • ACHV N/A
  • WHG $50.25
  • Revenue Growth
  • ACHV N/A
  • WHG 6.16
  • 52 Week Low
  • ACHV $3.03
  • WHG $10.75
  • 52 Week High
  • ACHV $5.98
  • WHG $18.03
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 39.51
  • WHG 60.24
  • Support Level
  • ACHV $4.19
  • WHG $15.67
  • Resistance Level
  • ACHV $4.46
  • WHG $17.18
  • Average True Range (ATR)
  • ACHV 0.24
  • WHG 0.67
  • MACD
  • ACHV -0.04
  • WHG 0.08
  • Stochastic Oscillator
  • ACHV 14.29
  • WHG 73.10

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals, and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high-net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: